October 25, 2016
Philip Ward
Advertisement
Philip Ward is ACT's European editor, phone +44 1244 538583, philipward1@btconnect.com
Articles by Philip Ward
August 05, 2016
October 22, 2015.
Advertisement
Latest Updated Articles
- Improved Access to Patient Data Holds Key to Future Therapies
Published: October 22nd 2015 | Updated:
- Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study
Published: February 19th 2016 | Updated:
- EMA Develops Strategy on Adaptive Pathways
Published: August 5th 2016 | Updated:
- EMA Gives Open Access to Clinical Data on New Medicines
Published: October 25th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
4
Sobi Reaches $1.5 Billion Definitive Agreement with Arthrosi Therapeutics to Acquire Gout Treatment
5
